Active Not RecruitingNCT06116890
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
PHASE2 · 180 planned enrolment
- Countries listed
- 4
- Registry update
- October 30, 2025
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–2 of 2. Every record below meets all the filters shown above.
PHASE2 · 180 planned enrolment
PHASE1 · 116 planned enrolment